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Abstract 
Yeasts are eukaryotes like us, and they have informed us about our cellular 
and molecular biology for many decades. They are unicellular and live with 
6000 genes, carrying out many of the same processes that we do. Like us, yeast 
exhibit the same processes of aging, with telomere shortening, loss of mito-
chondrial function, reduced proteostasis, reduced robustness and stress. Some 
of these attributes are associated with aging and may not be the cause of aging. 
Therefore, it is important to consider attributes that clearly affect the fitness of 
cells. We have constructed yeast with a reporter of deleterious protein turno-
ver. It involves the Alzheimer’s amyloid beta peptide fused to a green fluores-
cent protein to aid its visualization in living cells. The use of this reporter 
enables high throughput assays to find compounds that can improve proteos-
tasis in older cells. Compounds, like simvastatin, improve proteostasis and 
improve health outcomes inageing. Stress and biochemicals may decrease 
health and lifespan. Yeast can be used to study aging, drugs and stress, and to 
search for compounds that improve robustness in cells affected by drugs or 
stress. 
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1. Introduction 
The study of cellular and molecular biology is not at all easy in humans. Our 
knowledge tends to come from: 
• observations of people with natural “mutations”; 
• observations of people with respect to lifestyles and diets; 
• from experiments involving mammalian cell culture; 
• from experiments with mice; 
• from extrapolation from yeast and other model organisms, like the worm 
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Caenorhabditis elegans.  
Extrapolation from yeast may come as a surprise to the reader. In fact, yeast 
has contributed more to the knowledge of our basic biology than any other or-
ganism. Some recognition of this is seen in the large proportion of Nobel Prizes 
in Medicine and Chemistry that have been awarded for studies in yeast [1] [2], 
most often budding yeast, which represents the majority of yeast. 
While a yeast culture may seem immortal, the population within it is very he-
terogeneous, and a small fraction of the cells will be dead. Most yeast species ex-
hibit vegetative growth by budding. Cells grow and reach a point where they di-
vide by giving rise to new growth in a bud which eventually releases from the 
mother to form an independent new cell. Throughout their life cells continue to 
bud and with each bud they produce, there is a bud scar, so the age of the yeast 
(that is, how many buds she has produced) can be measured by the number of 
bud scars on the surface (see Figure 1). Using modern technologies, it is possible 
to study sub-populations of different age within a yeast culture. 
2. Ease of Use 
2.1. Yeast Culture and Single Cell Studies 
Yeasts have been cultured successfully for millennia in the manufacture of beer, 
wine and bread. Their culture is inexpensive and can utilize rich media as well as  
 
 
Figure 1. Growth of the budding yeast Saccharomyces cerevisiae seen in three genera-
tions. The first cell grows a bud which breaks off to leave a mother and daughter cell. The 
mother is left with a bud scar. Both repeat the process and each new mother is left with a 
bud scar. A third division is also shown, resulting in eight cells (bottom line) comprising 
four young cells without bud scars. The mothers of these cells may be relatively just one 
generation older (with one bud scar), and older mother cells with two or more bud scars. 
The oldest cell, with three bud scars, displays signs of aging (discussed in the text). Note 
that this diagram predicts a older cells to comprise ~12% of the population. 
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chemically defined synthetic media. This can ensure safety as well as the oppor-
tunity to extensively modify their nutritional environment to investigate effects 
on yeast health. In comparison, the culture of human cells is expensive and 
usually requires serum and/or growth factors, and these components need to be 
verified as being free of viruses and prions that could harm the researcher. Cell 
lines are often immortalized and not representative of primary cells that have a 
limited lifespan. Some of the most important cells for ageing studies, neuronal 
cells, are terminally differentiated and not normally amenable to cell culture.  
Looking at a yeast culture is somewhat like looking at our own population, in 
that there is a diversity of ages. In interrogating the aging human population, we 
analyse older people versus younger people: we can do the same comparison 
with yeast. This can be done with analytical flow cytometry, where the popula-
tion is analyzed one cell at a time by high-speed, high throughput machines that 
can measure and record the size, color, density, etc. of 10,000 cells or more in 
minutes. This information can then be further analyzed. For example, we might 
ask how the oldest cells are affected by treatment with a particular compound.  
Preparative flow cytometers (cell sorters) can help separate populations of 
cells so that they can be subjected to further examination, such as genome wide 
expression analyses. 
2.2. Yeast Genetics 
Yeast genetics have been studied for almost a century. Auxotrophic mutations in 
yeast were obtained to decipher biochemical pathways and they were freely dis-
tributed between yeast genetics laboratories throughout the world, rapidly aiding 
our knowledge of biochemical pathways. Yeast genetics greatly aided the 
emerging area of molecular biology in the 1980s and helped the establishment of 
gene and gene product relationships. It was convenient that yeast had very few 
introns, so the elucidation of the structure of the structure of the yeast nuclear 
genome in 1996, the first eukaryotic genome to be fully sequenced, was more 
straightforward. 
Since that time reverse genetics has been at play and the effects of most genes 
are now known. Such information has been used to inform about human genes 
with similar encoded functions. With the availability of yeast deletion libraries, 
we have a systematic view that many genes affect the lifespan of yeast, and many 
affect the health of cells. 
2.3. Yeast Mitochondrial Genome 
The mitochondrion is known as the powerhouse of the cell, and in humans its 
function declines with age, leading to cell death. In contrast, mitochondrial 
function in yeast is not obligatory but is dispensable. Loss of mitochondrial 
function in yeast simply means a loss of respiration, so the cells cannot grow on 
glycerol or ethanol. However, their growth is still reasonable on glucose. This 
yeast attribute improves the amount of information one can derive from yeast. 
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Many gene functions are required for stability of the mitochondrial genome, 
and it is clear that many mutations lead to high instability of the mitochondrial 
genome. Likewise, exposure to certain drugs or environments can lead to mito-
chondrial genome instability, including total loss of the mitochondrial genome.  
2.4. Telomere Maintenance 
Our cells are composed of linear chromosomes that need to be faithfully copied 
and transmitted to the new cells formed by cell division. Most of the DNA is co-
pied by a robust replication process where the copies are like mirror images of 
the originals, a so-called DNA template dependent process. However, the copy-
ing of the ends of the chromosomes, telomeres, is a special challenge, since it 
cannot use this process. Instead an enzyme, telomerase, orchestrates the building 
of the ends which contain highly repeated sequence of TTAGGG repeated as 
many as 3000 times. With age, it is noticed that telomeres shorten, so that by 40 
years of age telomeres can be half their original length. Interestingly, immorta-
lized cells like many cancers keep longer telomeres and overproduce telomerase. 
For this reason, there is interest in regulating telomerase as a possible interven-
tion in aging. Also, there is interest in monitoring telomerase as cancer bio-
marker, and targeting it in treatment of cancer. There is also interest in over-
producing telomerase to help preserve mammalian cell lines that are used in re-
search throughout the world. 
So far regulation of telomerase has not led to changes in longevity of animals 
or people. 
2.5. Proteostasis 
For the maintenance of cells there is a need to keep cellular components in equi-
librium. This can be achieved through the processes of proteostasis (protein de-
gradation through autophagy, proteosomal degradation, unfolded protein re-
sponse, etc.). Cells degrade proteins efficiently throughout our life, however, as 
we age proteostasis starts to fail. It is notable that in many diseases associated 
with ageing there is buildup of some proteins and this may account for the loss 
of many cell types, particularly neuronal cells, in the elderly. For example, in 
Alzheimer’s disease there is an accumulation of amyloid beta (Aβ), in Parkinson’s 
disease an accumulation of α-synuclein, and in Huntington’s disease an accumula-
tion of huntingtin in Huntington’s disease. Aβ, α-synuclein and huntingtin are 
proteins that are deleterious and their build-up leads to stress on cells. 
These processes can also be observed in yeast by tagging these problematic 
proteins with a fluorescent tag to enable their visualization in cells. Yeast cells 
were engineered to produce Aβ tagged with green fluorescent protein (to make 
GFP-Aβ), enabling it to be produced and seen in whole yeast cells [3]. It can be 
seen in Figure 2 that in young yeast cells the GFP-Aβ is degraded while in the 
older cells it persists. This shows old yeast to experience the same problems with 
proteostasis as old people.  
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Figure 2. Ageing and protein turnover in yeast. Left panel shows a mother cell (the larg-
est cell), with two buds, still attached. The middle panel shows calcofluor staining of two 
bud scars on the mother. The right panel shows GFP-Aβ in the mother: the daughter cells 
have received cytoplasm from the mother but have removed the GFP-Aβ.  
 
About 12% of the population (“grandparent” yeast and older with 2 or more 
bud scars) exhibit aging. Without any need for ethics approval, this population 
can be readily subjected to all sorts of treatments to find conditions that improve 
proteostasis (or that make it worse). 
Recently we have found that the cholesterol lowering drug, simvastatin, im-
proves protein turnover in old yeast cells (M. Subhan, K. Gardiner, R. Faryal and 
I. Macreadie, unpublished). In an untreated population, GFP-Aßwas visualized 
in 12% of yeast cells, but growth in the presence of simvastatin reduced this level 
to 0.6% of the population. In other words, simvastatin aided clearance of the de-
leterious GFP-Aβ in 95% of the older population. In parallel to this work two 
other statins, atorvastatin and lovastatin, were also tested. Atorvastatin and lo-
vastatin also significantly aided clearance of GFP-Aβ, but the reductions were 
not as great as those induced by simvastatin: atorvastatin led to a 60% decrease 
and lovastatin led to a 20% decrease in GFP-Aβ. These results in yeast are ex-
tremely informative about a role for statins in proteostasis in old yeast cells.  
Interestingly, in human cell lines and animal studies, statins have been shown 
to increase autophagy [4] [5] [6] [7] [8] and the unfolded protein response [9] 
[10].  
Most remarkable however, is that in a large epidemiological study of millions 
of people, simvastatin stands out among statins as a drug that lowers the inci-
dence of Alzheimer’s and Parkinson’s disease [11], which are leading causes of 
age-related morbidity. The yeast study, for the first time, suggests that statins 
might exert their protective effect through removal of Aβ. 
Further work is required to determine whether simvastatin might be exerting 
a protective effect in Parkinson’s disease through the removal of a deleterious 
protein like α-synuclein.  
3. Stress 
Stress has a major impact on our health and our survival. Stress may result from 
age, nutritional deprivation, mutations and environmental conditions, such as 
extreme cold or heat. Studies on care-givers show that the physical and psycho-
logical stresses they encounter decrease their survival [12] [13]. There are vari-
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ous biological blood markers, usually proteins, that can be used as indicators of 
stress levels. The measurement of such markers is made by pathology labs who 
compare levels in test samples with a reference range. It is important to keep 
daily stress at low levels to maintain good health. Continued high stress leads to 
a shorter lifespan and increased risk of disease. 
Yeasts, like other microbes, are masters in adapting to meet challenges and 
there is much we can learn from them. Their vast numbers in a population, and 
their variability due to mutation usually means that a variant is present that may 
survive a new challenge. Although it is not currently practical for humans to use 
this approach, we can learn from the yeast and possibly improve our resistance 
through pharmaceutical and nutraceutical interventions. 
Yeast also activates genes to help cope with the stress. Using genome wide ex-
pression analyses we can find out how they respond to the stress. Many genes 
are activated by stress and they have become known as stress-response genes. 
The same set of genes is induced by heat stress, reactive oxygen species and mis-
folded proteins. This set each have a specific “heat shock element” (HSE) up-
stream of the genes that respond to these stresses. They are all “switched on” in 
cells producing GFP-Aß, aiding in defense against the stress of this deleterious 
protein. 
Mounting stress responses may protect against stress but if there is no stress, 
the stress response may itself be harmful. For example, it is apparent that au-
toimmune diseases turn defense system against the body. Likewise, chronic in-
flammation appears to cause major debilitating diseases like chronic fatigue, fi-
bromyalgia and arthritis.  
In addition, there are other things to note in the analysis of the genome wide 
expression. One of the most highly induced genes, AHP1, encodes an allyl hy-
droperoxidase that is involved in detoxification of toxic lipid peroxides. This 
suggests oxidation of lipids may be involved in Aβ toxicity. 
The presence of GFP-Aβ induces stress in yeast and this can be measured by 
genome wide expression, or by reporter assays. For example, linking the HSE to 
a reporter gene like lacZ allows the detection of the lacZgene product, 
β-galactosidase, when cells are stressed. It can be seen that if the formation of 
Aβoligomers is inhibited, the cells are less stressed [3]. Likewise, this system can 
be used to screen for compounds that decrease stress on cells. 
4. Dealing with Toxic Natural Biochemical and  
Pharmaceuticals 
Our bodies produce and rely on thousands of biochemicals, including some that 
are toxic. One such example is the neurotransmitter dopamine. Dopamine is es-
sential and is produced by dopaminergic neurons, however, the loss of these 
neurons results in the age-related Parkinson’s disease (PD). PD is treated with 
L-DOPA, which is converted to dopamine in the brain, restoring neurotrans-
mission. Mammalian cell studies show that dopamine is actually toxic. Yeast 
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studies reveal that dopamine toxicity targets mitochondrial function, conve-
niently demonstrated in yeast by showing dopamine inhibits respiratory growth. 
Further, yeast demonstrate that protection from this inhibition can be obtained 
through the use of antioxidants like glutathione and ascorbate [14]. 
Other biochemicals that have been examined in yeast studies include biogenic 
amines, like tyramine (C. Kadkol and I. Macreadie, unpublished) and phenyl 
ethylamine [15], L-DOPA [16], and drugs like fluoxetine (K. Spencer-Bakes and 
I. Macreadie, unpublished). 
5. Conclusions 
Yeast can be used for many studies on aging and cell health. Yeast offers conve-
nient handling and quick results. 
Study of the cholesterol lowering drug, simvastatin, indicates that it also aids 
the clearance of a deleterious protein, and probably also does this in people, 
suggesting this may account for its beneficial effects in AD and PD. 
Stress can be observed in yeast, as well as agents that increase or decrease 
stress in yeast. 
Yeast can be used to study toxic biochemicals, as well as ways to reduce the 
toxicity of such biochemicals. 
Although some extrapolation is called for in applying yeast knowledge to hu-
man health, the lessons learned from yeast are valuable. 
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